2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
4
Recruiting
3
Withdrawn
2
Active not recruiting
2
Unknown
1
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Tongue Neoplasms
1
Interventions
Specimen Handling
34
Magnetic Resonance Spectroscopy
22
Biopsy
20
Cyclophosphamide
16
Nivolumab
10
Paclitaxel
9
Cisplatin
9
Gemcitabine
8
Bevacizumab
8
venetoclax
7
Vincristine
7
Prednisone
7
Doxorubicin
7
Azacitidine
7
pembrolizumab
6
Radiotherapy
6
Radiosurgery
6
Fluorouracil
6
Etoposide
6
Drug Therapy
6
Docetaxel
6
Taxes
5
Surgical Procedures, Operative
5
Rituximab
5
Oxaliplatin
5
Irinotecan
5
Everolimus
5
Capecitabine
5
fludarabine phosphate
4
fludarabine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Suspended
×
pimonidazole
×
Clear all
NCT03181035
2024-08-12
FAITH
Sunnybrook Health Sciences Centre
Phase 1/2
Suspended
10 enrolled